Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Simon Nebel Insider Profile
4 Followers
Simon Nebel, Director at Marinomed Biotech AG, holds ― shares in Marinomed Biotech AG (Ticker: DE:93Z). Most recently, Simon Nebel Bought €5,053 shares of Marinomed Biotech AG on Sep 20, 2024 for an estimated value of 25.27K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+14.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Simon Nebel does not currently own shares as a corporate insider.
A breakdown of Simon Nebel's holdings
Insider Roles
Director
Roles that Simon Nebel holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 06, 2019 - Feb 06, 2020
Return:+29.20%
The most profitable trade made by Simon Nebel
Simon Nebel's Trading History
List of latest transactions for each holding click on a transaction to see Simon Nebel's performance on stock
You May Also Like
Simon Nebel insider profile FAQ
What is the percentage of profitable transactions made by Simon Nebel?
The percentage of profitable transactions made by Simon Nebel is 50%.
What is the average return per transaction made by Simon Nebel?
The average return per transaction made by Simon Nebel is 14.60%.
What stocks does Simon Nebel hold?
Simon Nebel holds: DE:93Z stocks.
What was Simon Nebel’s latest transaction?
Simon Nebel latest transaction was an Informative Buy of €25.27K.
What was Simon Nebel's most profitable transaction?
Simon Nebel’s most profitable transaction was an Informative Buy of DE:93Z stock on February 6, 2019. The return on the trade was 29.20%.
What is Simon Nebel's role in Marinomed Biotech AG?
Simon Nebel's role in Marinomed Biotech AG is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.